Implementación de la entrevista de acceso privilegiado para caracterizar consumidores de pasta base de cocaína

Santis B., Rodrigo; Hayden C., Viviana; Ruiz P., Sergio; Anselmo M., Enzo; Torres B., Rafael; Pérez de Los Cobos P., José.
Rev. chil. neuro-psiquiatr ; 42(4): 273-280, oct. 2004. tab, graf
Artículo en Español | LILACS | ID: lil-399749

Documentos relacionados

  1. Cocaine vaccine dAd5GNE protects against moderate daily and high-dose "binge" cocaine use.
  2. Anti-cocaine vaccines: antibody protection against relapse.
  3. Sub-lethal toxicity and elimination of the cocaine metabolite, benzoylecgonine: a narrative review.
  4. DBH gene as predictor of response in a cocaine vaccine clinical trial.
  5. Cocaine contamination of banknotes: a review.
  6. Immune to addiction: the ethical dimensions of vaccines against substance abuse.
  7. Computational Design and Crystal Structure of a Highly Efficient Benzoylecgonine Hydrolase.
  8. Hair toxicological analysis of infants and their mothers: a 5-year retrospective study focusing on cocaine.
  9. Monitoring of the stability of cocaine and some metabolites in water and oral fluid by a newly developed CE method.
  10. Environmental enrichment protects against the acquisition of cocaine self-administration in adult male rats, but does not eliminate avoidance of a drug-associated saccharin cue.